Rabbit Syndrome: Update on aetiology and management for pharmacists, psychiatrists and dentists
Abstract
Rabbit syndrome (RS) is an involuntary movement disorder, characterized by fast and fine movements of oral and masticatory muscles along the mouth vertical axis in the absence of tongue involvement. RS prevalence varies between 2.3% to 4.4% and could result from the administration of antipsychotics and antidepressants. In case of second generation antipsychotics, there is a reduced risk of RS compared with first generation antipsychotics with mainly isolated literature case reports especially with the use of risperidone as antipsychotic. RS affects only the buccal region, with the possible involvement of the basal ganglia, in particular the substantia nigra. The management of RS include reduction or change of the psychotropic treatment and use of anticholinergic medications such as trihexyphenidyl. Although RS is rare and easily treatable, it is essential that dentists and psychiatrists could distinguish this syndrome from other movement disorders such as tardive dyskinesia.
Citations
Altmetric:
Date
2019-03
Type
Article
Subject
Pharmacology
Citation
Ayman Antoun Reyad, Eriny Girgis and Raafat Mishriky (2019) ' Rabbit Syndrome: Update on Aetiology and Management for Pharmacists, Psychiatrists And Dentists', International Journal of Current Medical And Pharmaceutical Research, 05(03), pp 4103-4105.
Journal / Source Title
International Journal of Current Medical and Pharmaceutical Research
DOI
10.24327/23956429.ijcmpr201902631
PMID
Publisher
IJCMPR Publications
Publisher’s URL
https://journalcmpr.com/issues/rabbit-syndrome-update-aetiology-and-management-pharmacists-psychiatrists-and-dentists